專業旅運(01235.HK)年度預虧3150萬至3450萬港元
格隆匯6月11日丨專業旅運(01235.HK)發佈公吿,預期集團截至2021年3月31日止年度將錄得公司擁有人應占虧損介乎約3150萬港元至3450萬港元,而去年公司擁有人應占虧損約4530萬港元。
公吿表示,該年度公司擁有人應占虧損主要由於爆發2019冠狀病毒病所致。因應全球爆發COVID-19而令形勢不斷演變且難以預測,各國政府實施了嚴格的旅遊限制及隔離措施,此前所未有的挑戰令集團收益大幅減少,亦對集團於該年度的財務表現產生不利影響。儘管如此,集團管理層已採取有效節流措施,包括但不限於縮減分行網絡、減低員工成本及與業主磋商減租。董事會認為集團持有足夠營運資金以應付營運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.